Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2002 2
2003 3
2004 3
2005 2
2006 2
2007 3
2008 3
2009 2
2010 3
2011 1
2013 1
2014 6
2015 3
2016 4
2017 9
2018 10
2019 5
2020 13
2021 7
2022 8
2023 2
2024 6
2025 23
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2025 May;15(2_suppl):793S-822S. doi: 10.1177/21925682251336882. Epub 2025 May 21. Global Spine J. 2025. PMID: 40397527 Free PMC article. No abstract available.
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial.
Yamashita T, Saji S, Takano T, Naito Y, Tsuneizumi M, Yoshimura A, Takahashi M, Tsurutani J, Iwatani T, Kitada M, Tada H, Mori N, Higuchi T, Iwasa T, Araki K, Koizumi K, Hasegawa H, Uchida Y, Morita S, Masuda N. Yamashita T, et al. J Clin Oncol. 2025 Apr 10;43(11):1302-1313. doi: 10.1200/JCO-24-01888. Epub 2025 Jan 9. J Clin Oncol. 2025. PMID: 39787453 Free PMC article. Clinical Trial.
AI-based computer-aided diagnosis (AI-CAD): the latest review to read first.
Fujita H. Fujita H. Radiol Phys Technol. 2020 Mar;13(1):6-19. doi: 10.1007/s12194-019-00552-4. Epub 2020 Jan 2. Radiol Phys Technol. 2020. PMID: 31898014 Review.
The third artificial intelligence (AI) boom is coming, and there is an inkling that the speed of its evolution is quickly increasing. ...Under these circumstances, AI has evolved and diversified at a remarkable pace in medical diagnosis, especially in diagnostic ima …
The third artificial intelligence (AI) boom is coming, and there is an inkling that the speed of its evolution is quickly increasing. …
Wnt/β-Catenin Signaling Regulates Hepatitis B Virus cccDNA Levels.
Ishida A, Iwabuchi S, Li YY, Murai K, Shirasaki T, Kuroki K, Shimakami T, Nio K, Kawaguchi K, Imafuku T, Ito S, Yamashita T, Kaneko S, Yanagawa H, Matsushima K, Honda M, Hashimoto S. Ishida A, et al. Int J Mol Sci. 2025 Jul 19;26(14):6942. doi: 10.3390/ijms26146942. Int J Mol Sci. 2025. PMID: 40725188 Free PMC article.
The DOCK11-associated gene, Wnt/beta-catenin signaling regulator tankyrase (TNKS), was identified using in vitro methods; however, its function in the HBV life cycle remains unknown. Here, we used various inhibitors, antagonists, and short-hairpin RNA treatme …
The DOCK11-associated gene, Wnt/beta-catenin signaling regulator tankyrase (TNKS), was identified using in vitro methods; however, its funct …
Pioneering AI-guided fluorescence-like navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network.
Chen W, Fukuda S, Yoshida S, Kobayashi N, Fukada K, Fukunishi M, Otani Y, Matsumoto S, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukushima H, Fu G, Waseda Y, Tanaka H, Fujii Y. Chen W, et al. J Robot Surg. 2025 Apr 30;19(1):188. doi: 10.1007/s11701-025-02340-2. J Robot Surg. 2025. PMID: 40304828
Artificial intelligence (AI)-driven intraoperative navigation in urological surgery can enhance surgical precision through real-time structure identification and tracking. ...In the clinical utility assessment, 62.22% (60.00%-64.44%) of the AI-inferred images were c …
Artificial intelligence (AI)-driven intraoperative navigation in urological surgery can enhance surgical precision through real-time …
Interactions of APOBEC3s with DNA and RNA.
Maiti A, Hou S, Schiffer CA, Matsuo H. Maiti A, et al. Curr Opin Struct Biol. 2021 Apr;67:195-204. doi: 10.1016/j.sbi.2020.12.004. Epub 2021 Jan 22. Curr Opin Struct Biol. 2021. PMID: 33486429 Free PMC article. Review.
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutations.
Iwama E, Sakai K, Harada T, Kanda S, Sugawara S, Yokoyama T, Taniguchi H, Tanaka K, Toyozawa R, Koyama K, Zenke Y, Kida G, Nishioka Y, Yokouchi H, Hirose M, Nishio K, Yamamoto N, Ohe Y, Okamoto I. Iwama E, et al. Lung Cancer. 2025 Oct;208:108756. doi: 10.1016/j.lungcan.2025.108756. Epub 2025 Sep 16. Lung Cancer. 2025. PMID: 40974872 Free article. Clinical Trial.
Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations.
Mouri A, Kaira K, Yamaguchi O, Shiono A, Miura Y, Hashimoto K, Yamasaki S, Nishihara F, Imai H, Kobayashi K, Kagamu H. Mouri A, et al. Cancer Immunol Immunother. 2025 Jul 12;74(8):265. doi: 10.1007/s00262-025-04113-0. Cancer Immunol Immunother. 2025. PMID: 40650761 Free PMC article.
BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) control lung cancer in patients with EGFR mutations, but resistance develops over time. ...
BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) control lung cancer in patients with EGFR mutatio …
117 results